The breast cancer risk assessment test that detected Olivia Munn's aggressive Luminal B cancer has now identified breast ...

Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

Scientists have discovered a protein that acts like a “suit of armour” for skin cancer cells in a breakthrough that could ...

A routine eye appointment led to the discovery of a rare cancer for a Hampshire woman. Lynsey Schulkins, 43, first noticed ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Mary Beckerle is stepping down from her long tenure as CEO of Huntsman Cancer Institute at the University of Utah. Beckerle ...

Landmark research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some promising cancer treatments are causing serious side effects, and offers ...

The researchers engineered a compound that kills leukemia cells with potency comparable to FDA-approved therapies by ...

We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

The TCR report forecasts that by 2032 prostate cancer will increase steadily and remain the number one cancer of concern ...